![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 37, 34329-34335, September 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Skin-stage schistosomula of Schistosoma
mansoni were found to secrete molecules that are pro-apoptotic
for skin T lymphocytes as measured by annexin V staining, caspase-3
activity, caspase-8 activities, and DNA fragmentation. Caspase-8
activities in lymphocytes peaked ~8 h and caspase-3 activity peaked
~16 h after exposure to the parasite secretions. Subset analysis
showed that mainly CD4+ and CD8+ cells (but not
B cells) were susceptible to the parasite-induced pro-apoptotic
effect. In situ staining confirmed the presence of
apoptotic T cells around challenge parasites in the skin of naive or
immunized animals. Analysis of T cells to identify the potential
molecular pathway of the parasite-induced apoptosis showed increases in
the expression of Fas, FasL, and the Fas-associated death domain.
Blocking of FasL with a fusion protein reversed the parasite-induced
apoptosis, suggesting a role for the Fas/FasL-mediated pathway in the
parasite-induced T cell apoptosis. Subsequent analyses of the
secretions of skin-stage schistosomula identified the pro-apoptotic activity as being associated with a protein of ~23 kDa. This protein was termed S. mansoni-derived apoptosis-inducing factor.
Skin-stage Schistosomula of Schistosoma
mansoni Produce an Apoptosis-inducing Factor That Can Cause
Apoptosis of T Cells*
,
, and
¶
Department of Biomedical Sciences, College
of Medicine, University of Illinois, Rockford, Illinois 61107 and
the § Department of Biomedical Engineering, Northwestern
University, Evanston, Illinois 60208
*
This work was supported by National Institutes of Health
Grant AI 39066 (to K. R.). Life cycle stages of S. mansoni
were obtained from Dr. Fred Lewis through NIAID Contract N01-A1-55270
from the National Institutes of Health.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
J. Bohannon, W. Cui, R. Cox, R. Przkora, E. Sherwood, and T. Toliver-Kinsky Prophylactic Treatment with Fms-Like Tyrosine Kinase-3 Ligand after Burn Injury Enhances Global Immune Responses to Infection J. Immunol., March 1, 2008; 180(5): 3038 - 3048. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |